Stellar Biotech Inc (SBOTF) 0.8000 $SBOTF Stellar

New Post Public Reply Private Reply Replies (0) Message Board

Sep 12, 2015 at 2:45 PM

Stellar Biotech Inc (SBOTF) 0.8000 $SBOTF

Stellar Biotechnologies Announces Reverse Stock Split in Preparation for Proposed Uplisting to NASDAQ Capital Market
Marketwired - Fri Aug 28, 7:30AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"

, today announced that, subject to regulatory approval, the Company will proceed with a consolidation of its issued and outstanding common shares (the "Shares"

on the basis of one (1) post-consolidated common Share for every ten (10) pre-consolidated Shares (the "Reverse Split"

.
KLH.VN: 9.100 (-0.890)

Stellar Biotechnologies Reports Third Quarter 2015 Financial Results and Operational Highlights
Marketwired - Mon Aug 10, 7:30AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"

, an important immune-stimulating protein used in wide-ranging immunotherapy markets, today announced its financial results for the third fiscal quarter ended June 30, 2015.
KLH.VN: 9.100 (-0.890)

Stellar Biotechnologies Signs Collaboration Agreement to Expand KLH Aquaculture Operations
Marketwired - Tue Jul 28, 7:30AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or the "Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH), a leading provider of Keyhole Limpet Hemocyanin (KLH) protein, today announced that the Company has entered into a collaboration agreement with Ostiones Guerrero SA de CV ("Ostiones"

(the "Agreement"

to secure a unique strategic site in Baja California, Mexico for the development of an additional aquaculture locale and expansion of Stellar KLH(TM) production to meet the increasing needs of its customers.
KLH.VN: 9.100 (-0.890)

Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Therapeutics Pipeline Report 2015 - 37 Companies & 57 Drug Profiles
M2 - Tue Jul 21, 10:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/vgmkjs/clostridium) has announced the addition of the "Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Clostridium Difficile Infections (Clostridium Difficile Associated Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Clostridium Difficile Infections (Clostridium Difficile Associated Disease) and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - Absynth Biologics Limited - Actelion Ltd - ActogeniX NV - Adenium Biotech ApS - AIMM Therapeutics B.V. - Akthelia pharmaceuticals ehf - AmpliPhi Biosciences Corporation - Assembly Biosciences, Inc. - AvidBiotics Corp. - C3 Jian, Inc - Daiichi Sankyo Company, Limited - Evec, Inc. - GangaGen Inc. - ImmunoBiology Ltd. - Immuron Limited - Inovio Pharmaceuticals, Inc. - MedImmune, LLC - Merck & Co., Inc. - MGB Biopharma Limited - Microbiotix, Inc. - Micropharm Ltd - Nanotherapeutics, Inc. - Novabiotics Ltd - Oragenics, Inc. - Pfizer Inc. - Procarta Biosystems Ltd - Prokarium Ltd. - Sanofi Pasteur SA - Sarum Biosciences Limited - Sequella, Inc. - Shire Plc - Sorrento Therapeutics, Inc. - Stellar Biotechnologies, Inc. - Summit Therapeutics plc. - Synthetic Biologics, Inc. For more information visit http://www.researchandmarkets.com/research/vg...lostridium
PFE: 32.97 (+0.35), SRNE: 13.53 (+0.25), APHB: 7.19 (+0.02), INO: 7.34 (+0.23), SYN: 2.62 (+0.18), MRK: 52.09 (-0.63), SHPG: 223.00 (-2.43), ASMB: 13.98 (+0.01), OGEN: 2.55 (unch)

Stellar Biotechnologies Retains The Ruth Group to Advance Communications Objectives
Marketwired - Thu Jul 09, 7:30AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or the "Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH), a leading provider of Keyhole Limpet Hemocyanin (KLH) protein, a crucial component for the development of many novel immunotherapies, today announced that it has retained New York City-based investor and public relations agency The Ruth Group as its strategic communications advisors.
KLH.VN: 9.100 (-0.890)

Stellar Biotechnologies to Present at 5thAnnual LD Micro Invitational
Marketwired - Mon Jun 01, 7:30AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or the "Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH) today announced that Stellar executives will present at the 5th Annual LD Micro Invitational Conference, being held June 1-3, 2015 at the Luxe Sunset Boulevard Hotel, Los Angeles, CA.
KLH.VN: 9.100 (-0.890)

Stellar Biotechnologies to Present at 2015 Marcum MicroCap Conference
Marketwired - Wed May 27, 7:30AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or the "Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH) today announced that Company executives will present at the 2015 Marcum MicroCap Conference, being held May 27-28, 2015 at the Grand Hyatt in New York City, NY.
KLH.VN: 9.100 (-0.890)

Stellar Biotechnologies' Immunology 2015 Poster Available Online
Marketwired - Fri May 15, 7:30AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or the "Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH) today announced that the Company's poster presentation at this week's IMMUNOLOGY 2015 conference, the Annual Meeting of the American Association of Immunologists (AAI), has been posted to the Company's website. http://tinyurl.com/n5hq43w.
KLH.VN: 9.100 (-0.890)

Stellar Biotechnologies Expands Online Corporate Communications Channels
Marketwired - Thu May 14, 7:30AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or the "Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH), today announced that the Company is expanding its online corporate communications channels to include Twitter, Facebook, and Google+/YouTube.
KLH.VN: 9.100 (-0.890)

Stellar Biotechnologies Reports Second Quarter 2015 Financial Results
Marketwired - Mon May 11, 3:30PM CDT
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"

, an important immune-stimulating protein used in wide-ranging immunotherapeutic markets, today announced its financial results for the second fiscal quarter and six months ended March 31, 2015.
KLH.VN: 9.100 (-0.890)

Stellar Biotechnologies Presents Poster at Immunology 2015 on the Immunogenicity of Different Forms and Preparations of KLH
Marketwired - Thu Apr 30, 7:30AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or the "Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH) today announced the presentation of results from preclinical studies analyzing the immunogenicity of different forms and preparations of Keyhole Limpet Hemocyanin (KLH), and relating to the Company's work in developing methods to identify the appropriate functional properties of KLH for use in immunotherapy and immunodiagnostic applications.
KLH.VN: 9.100 (-0.890)

Stellar Biotechnologies and Neovacs S.A. Expand KLH Supply Relationship
Marketwired - Wed Apr 01, 1:00AM CDT
Stellar Biotechnologies, Inc. ("Stellar" or the "Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH) and Neovacs S.A. ("Neovacs"

(ALTERNEXT PARIS: ALNEV) today announced that the Companies have entered into an expanded supply agreement to meet Neovacs' requirements for Keyhole Limpet Hemocyanin (KLH), a primary component of Neovacs' proprietary Kinoid immunotherapy technology.
KLH.VN: 9.100 (-0.890)

First FDA Breakthrough Therapy Designation for KLH-Conjugate Immunotherapy Signals Key Step for Novel Carrier Molecule
Marketwired - Tue Mar 10, 4:32PM CDT
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"

is encouraged that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for a KLH-based immunotherapy compound in the treatment of adult patients with EGFRvIII-positive glioblastoma being developed by Celldex Therapeutics, Inc.
KLH.VN: 9.100 (-0.890)

Stellar Biotechnologies Reports First Quarter 2015 Financial Results
Marketwired - Mon Feb 09, 7:30AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"

, an important immune-stimulating protein used in wide-ranging immunotherapeutic markets, announced financial results for the first quarter period ended December 31, 2014.
KLH.VN: 9.100 (-0.890)

Stellar Biotechnologies to Present at Biotech Showcase(TM) 2015 Conference
Marketwired - Thu Jan 08, 7:31AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH) announced today that the Company's management team will present at the 7th Annual Biotech Showcase 2015 conference, being held at the Parc 55 Wyndham Hotel in San Francisco, CA, on Tuesday, January 13 at 2:30 p.m. PST.
KLH.VN: 9.100 (-0.890)

Stellar Biotechnologies to Present at LD Micro Conference
Marketwired - Mon Nov 24, 7:31AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH) announced today the Company's management team will present at the upcoming LD Micro Conference on Tuesday, December 2 at 1:00 p.m. PST.
KLH.VN: 9.100 (-0.890)

Stellar Biotechnologies misses by $0.03, revenue in-line
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 9:55AM CST

Stellar Biotechnologies Reports Year-End 2014 Financial Results
Marketwired - Thu Nov 13, 9:17AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"

, an important immune-stimulating protein used in wide-ranging immunotherapeutic markets, has reported preliminary financial results for the year ended August 31, 2014.
KLH.VN: 9.100 (-0.890)

Stellar Biotechnologies and Araclon Biotech Sign Exclusive KLH Supply Agreement for Clinical Trials in Alzheimer's Active Immunotherapies
Marketwired - Tue Nov 11, 11:46AM CST
Stellar Biotechnologies, Inc. ("Stellar" or "the Company"

(OTCQB: SBOTF) (TSX VENTURE: KLH) and Araclon Biotech SL ("Araclon"

today announced that the companies have executed a definitive exclusive supply agreement to meet Araclon's Phase (II and III) clinical trial requirements for Keyhole Limpet Hemocyanin (KLH) used in Araclon's active immunotherapies against Alzheimer's disease.
KLH.VN: 9.100 (-0.890)

Stellar Bio tech chief bids adieu
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 3:05PM CST

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CJ BIO's Bold Steps for Sustainable Animal Nutrition

Breaking New Ground in Animal Nutrition Picture this: industry big wigs and farmers alike, all rubbing elbows at EuroTier 2026, the grand meeting ground for animal nutrition's future. This is where CJ BIO is flexing its muscles, not by just tossing ingredients into the mix, but by revolutionizing them under the banner "Feed Intelligence for Sustainable Performance." Now,...

Context Labs Unveils AI Distillery for Enterprises

Rethinking AI with Sovereignty in Mind A bouquet of tech buzzwords lands on every investor's doorstep with the unveiling of Context Labs' latest contraption. We’re talking about the AI Distillery™, which promises enterprises a way to run sovereign AI systems by keeping data in-house. Now, if you’re nodding along to the buzz, let's cut through the clutter....

Smart Salary Moves for S Corp Owners: Riggs Unpacks Insights

Decoding the S Corp Salary Dance How much salary should the savvy owners of S corporations draw? It ain't a simple task or one-size-fits-all deal, folks. David Riggs spills the beans on HelloNation, sharing insights on this complex tango between drawing wages and raking in shareholder distributions. In the end, it’s about playing by the IRS rules—or risking a penalty...

Dutch Bros Pours Holiday Cheer with New Festive Menu

New Festive Offerings from Dutch Bros Kicking off the holiday season with a splash of vibrant flavors, Dutch Bros is shaking up the menu with some fresh, festive entries. Two new drink concoctions hit the stage alongside a themed delectable treat, and for those traditionalists, perennial favorites make a triumphant return. Dutch Bros Expands Its Vibrant Lineup It's not...

UBCF Strikes Big in Times Square with New Billboards

From the Shadows to the Spotlight Ever seen someone step up to the plate and knock it out of the park? That's what the United Breast Cancer Foundation (UBCF) is doing by plastering their mission right across Times Square. Talk about grabbing the bull by the horns, eh? With not one, but two billboards now gracing one of the globe's most iconic public spaces, they've...

Why Accurate HVAC Load Calculations Matter

Beyond Square Footage: Critical HVAC Considerations When it comes to heating and cooling your home, simply considering its square footage is like trying to predict the weather with nothing but a coin flip. Bob Schmid, an HVAC guru from Ocean View, NJ, pulls back the curtain on why the details really matter in determining the most efficient and effective HVAC setup for any...

Shenzhen's Theme Song Unveils APEC 2026 Vision

A Harmonious Prelude to APEC China 2026 Ever experienced an anthem that captures a city's pulse? That's what Shenzhen's latest creation aims for as it gears up for APEC China 2026. The Publicity Department of the CPC Shenzhen Municipal Committee, alongside Shenzhen Media Group, has crafted something more than just a tune. This is 'Meet You Where Wonders Bloom', a melody...

SKYWORTH Solar's Solavita: Energizing Global Microgrids

Aiming for Global Reach with Solavita Usually, when a company flings a new brand into the arena, you're looking at a whole bunch of promises and probably a fat folder of paperwork you don't want to read. But when SKYWORTH Solar dishes out Solavita as its new ace in the smart microgrid game, you reckon there's a bit of serious starch in the collar. Harnessing Worldwide...

Wulcea Pioneers Safety in Smart Heated Apparel

Tech Behind the Warmth and Safety You ever turn on a heated jacket and wonder if it'll keep you safe as much as warm? That's the scene with Wulcea, a brand diving headfirst into the smart heated clothing market. People are waking up to what’s inside these technological coats, not just how they feel on a frosty walk. It’s the kind of scenario where safety meets...

China-Malaysia Youth Dialogue: Tackling Ocean Challenges

Building Bridges Across Waters These aren't the afternoons of trading stocks, folks—this one dives into the depths of the ocean and the tumultuous waters between China and Malaysia. October 30 saw the China-Malaysia Youth Ocean Dialogue take place at the China Media Group Sanya Studio, bringing together some sharp minds from both nations, tackling something that goes...